Search results
Geron Announces FDA Approval of RYTELO™ (imetelstat), a First-in-Class Telomerase Inhibitor, for the...
Benzinga· 3 hours agoApproval across ESA ineligible and ESA relapsed/refractory patients with LR-MDS with transfusion-dependent anemia, regardless of ring sideroblast (RS) status Durable and sustained red blood cell transfusion
Sarcoma immunotherapy clinical trial reduces risk of relapse by 43%
Medical Xpress· 3 days agoFor the last three decades, breakthroughs have been sparse for soft tissue sarcomas, which are rare...
TECVAYLI® (teclistamab-cqyv) shows sustained deep and durable responses in patients with relapsed or...
Valley City Times Record· 4 days ago"With the longest follow-up of any bispecific antibody, teclistamab demonstrates continued deep and durable responses observed in patients with relapsed or refractory multiple ...
Triplet Notches Survival Win in Heavily Pretreated DLBCL
MedPage Today· 5 days agoBenefit with BV plus lenalidomide-rituximab seen in those who relapsed after CAR-T or transplant
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer
Motley Fool via Yahoo Finance· 3 days agoPfizer has raised its dividend payout every year since 2009. The stock is down because COVID-19...
Binge-Eating Disorder May Linger for Years
Medscape· 3 days agoBinge-eating disorder (BED) often improves with time, but full remission can take many years and relapse is common, new research suggested. "The big...
In Baltimore’s Senior Homes, Overdoses Plague a Forgotten Generation
The New York Times via Yahoo News· 4 days agoBALTIMORE — Larnell Robinson sat at a desk in his cluttered office last September, between a...
Six-Time Cancer Survivor Runs a Marathon on Every Continent
Runner s World· 2 days agoFor the last mile of the Antarctica Marathon, Jonathan Acott played one song on repeat. It was a...
Guest column: With FDA approval of software treatment for depression, the digital medicine...
WRAL TechWire· 7 days agoIn a watershed moment for digital health innovation, the FDA recently granted clearance to Rejoyn, a...
MS Med Nearly Eliminates Disease Activity on MRI
Medscape· 2 days agoA second-generation anti-CD40L monoclonal antibody suppresses multiple sclerosis (MS) disease activity on MRI to an uncommonly high degree, new trial data suggested. Researchers found a near ...
